Guardant Health Future Growth
Future criteria checks 2/6
Guardant Health is forecast to grow earnings and revenue by 20.2% and 23.2% per annum respectively while EPS is expected to grow by 22.4% per annum.
Key information
20.2%
Earnings growth rate
22.4%
EPS growth rate
| Healthcare earnings growth | 27.7% |
| Revenue growth rate | 23.2% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 730 | -469 | -450 | -375 | 13 |
| 12/31/2023 | 571 | -539 | -540 | -483 | 17 |
| 12/31/2022 | 446 | -641 | -388 | -302 | 17 |
| 9/30/2022 | 431 | -606 | -388 | -296 | N/A |
| 6/30/2022 | 408 | -551 | -363 | -271 | N/A |
| 3/31/2022 | 391 | -419 | -309 | -221 | N/A |
| 12/31/2021 | 374 | -406 | -284 | -209 | N/A |
| 9/30/2021 | 344 | -409 | -249 | -191 | N/A |
| 6/30/2021 | 324 | -379 | -191 | -146 | N/A |
| 3/31/2021 | 298 | -336 | -143 | -107 | N/A |
| 12/31/2020 | 287 | -254 | -158 | -104 | N/A |
| 9/30/2020 | 271 | -185 | -129 | -75 | N/A |
| 6/30/2020 | 258 | -120 | -118 | -66 | N/A |
| 3/31/2020 | 245 | -77 | -102 | -56 | N/A |
| 12/31/2019 | 214 | -76 | -68 | -47 | N/A |
| 9/30/2019 | 184 | -76 | -60 | -43 | N/A |
| 6/30/2019 | 145 | -87 | -81 | -67 | N/A |
| 3/31/2019 | 111 | -97 | -89 | -70 | N/A |
| 12/31/2018 | 91 | -85 | -92 | -72 | N/A |
| 9/30/2018 | 78 | -75 | -85 | -64 | N/A |
| 6/30/2018 | 67 | -84 | -87 | -68 | N/A |
| 3/31/2018 | 57 | -83 | -77 | -65 | N/A |
| 12/31/2017 | 50 | -89 | -81 | -72 | N/A |
| 12/31/2016 | 25 | -46 | -38 | -37 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 5GH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 5GH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 5GH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 5GH's revenue (23.2% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: 5GH's revenue (23.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 5GH's Return on Equity is forecast to be high in 3 years time